Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 45Recruiting 15Unknown 8Active not recruiting 6Terminated 4Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Stress, Psychological 1Motor Activity 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Cognitive Behavioral Therapy × Clear all
NCT04815746 2024-11-26

QOL and GI Outcomes in Malignancies

University of Miami

Phase NA Withdrawn

Stress, Psychological

NCT03176888 2020-03-25

Health Benefits of HIT for Breast Cancer Patients

University of Stirling

Phase NA Withdrawn
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡